Benchmark Co. upgraded shares of Invitae Corporation (NYSE:NVTA) from a hold rating to a buy rating in a research note released on Tuesday.

Separately, Leerink Swann reiterated an outperform rating on shares of Invitae Corporation in a research note on Wednesday, November 9th.

Shares of Invitae Corporation (NYSE:NVTA) opened at 9.61 on Tuesday. The company has a 50 day moving average price of $8.74 and a 200 day moving average price of $8.09. Invitae Corporation has a 52 week low of $5.76 and a 52 week high of $11.85. The company’s market capitalization is $348.31 million.

This piece of content was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of US and international trademark and copyright legislation. The original version of this piece of content can be accessed at

About Invitae Corporation

Invitae Corporation (Invitae) utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients.

5 Day Chart for NYSE:NVTA

Receive News & Ratings for Invitae Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invitae Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.